Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STORM-RA
NCT07245732Phase 4Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Apr 2026
- Primary completion
- Mar 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone injection, prednisone in rheumatoid arthritis (RA), sponsored by Sunnybrook Health Sciences Centre. Started Apr 2026; status: recruiting.
02
Drugs
methylprednisolone injectionprednisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07245732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245732.